In collaboration with expert physicians in pediatric and adult gastroenterology, AGA and the Academy for Continued Healthcare Learning (ACHL) developed the linked education hub to support delivery and practical application of the latest data and guidance in SBS.
The hub provides everything you need whether you’re a practitioner looking to stay on top of the latest advances in SBS through personalized CME, train as an educator for your team or other sites, or a hospital/clinic looking to support your educational programming.
More Information
Faculty:
Donald F. Kirby, MD
Director, Center for Human Nutrition
Medical Director, Intestinal Transplant Program
Department of Gastroenterology, Section of Nutrition
Cleveland Clinic
Cleveland, OH
Samuel A. Kocoshis, MD
Professor, Pediatrics
University of Cincinnati College of Medicine, Cincinnati Children’s Hospital
Medical Director, Intestinal Transplant and Intestinal Care Center
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Outline dietary and drug treatment strategies for achieving and maintaining enteral autonomy and promoting intestinal absorption in diverse patients with SBS
- Describe challenges and unmet needs with parenteral nutrition and identify strategies to reduce patient dependency on parenteral support
- Implement system-based tools and best practices for providing coordinated, multidisciplinary care for patients with SBS
- Implement communication and shared decision-making strategies for patients and their caregivers to achieve enteral autonomy
- Develop individualized, state of the art SBS care plans for diverse groups of patients
Disclosures
Brooks D. Cash, MD, FACP, FACG, FASGE, AGAF, RFF, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.
Grant/Research Support from AbbVie Inc.; Ardelyx; QOL Medical, LLC; and Takeda Pharmaceuticals U.S.A., Inc.
Speakers Bureau participant with Salix Pharmaceuticals.
Johannah Ruddy, MEd, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Mahana Therapeutics, Inc.
Speaker for AbbVie Inc.; Mahana Therapeutics, Inc.; and Salix/Bausch Health Companies Inc.
Other Financial or Material Support as an independent contractor for Salix/Bausch Health Companies Inc.
Other AGA and PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: Jan. 31, 2023
